ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 174.02%
This Quarter Est. Return
1 Year Est. Return
+174.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1
+$27.5M
2
+$21.3M
3
+$21.3M
4
ETNB
89bio
ETNB
+$18.2M
5
LXEO icon
Lexeo Therapeutics
LXEO
+$9.21M

Top Sells

1
+$146M
2
+$18.6M
3
+$11M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$8.49M
5
RAPT icon
RAPT Therapeutics
RAPT
+$7.1M

Sector Composition

1 Healthcare 87.56%
2 Financials 1.74%
3 Consumer Discretionary 0.24%
4 Communication Services 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
26
Ionis Pharmaceuticals
IONS
$13.3B
$8.75M 0.82%
133,818
-14,643
JANX icon
27
Janux Therapeutics
JANX
$2.04B
$8.58M 0.81%
351,032
+288,944
IKT icon
28
Inhibikase Therapeutics
IKT
$182M
$8.5M 0.8%
5,247,603
+125,498
IVVD icon
29
Invivyd
IVVD
$693M
$8.11M 0.76%
+7,370,987
MTSR
30
DELISTED
Metsera Inc
MTSR
$7.98M 0.75%
+152,521
EQ icon
31
Equillium
EQ
$52.4M
$7.95M 0.75%
+5,559,988
PCSC
32
Perceptive Capital Solutions
PCSC
$119M
$7.92M 0.74%
750,000
QURE icon
33
uniQure
QURE
$1.66B
$7.78M 0.73%
+133,316
PCVX icon
34
Vaxcyte
PCVX
$5.96B
$7.67M 0.72%
213,064
+115,032
RZLT icon
35
Rezolute
RZLT
$850M
$7.67M 0.72%
815,975
-173,322
XENE icon
36
Xenon Pharmaceuticals
XENE
$3.36B
$7.59M 0.71%
189,098
-70,405
ASND icon
37
Ascendis Pharma
ASND
$12.9B
$7.23M 0.68%
36,345
+34,943
SVRA icon
38
Savara
SVRA
$1.19B
$7.1M 0.67%
1,988,288
-1,612,382
SRPT icon
39
Sarepta Therapeutics
SRPT
$2.07B
$6.74M 0.63%
349,807
+139,494
RVMD icon
40
Revolution Medicines
RVMD
$14.7B
$6.5M 0.61%
139,136
+5,000
AAM
41
AA Mission Acquisition Corp
AAM
$466M
$6.08M 0.57%
578,359
BBOT
42
BridgeBio Oncology
BBOT
$977M
$5.8M 0.55%
501,228
+58,613
VRNA
43
DELISTED
Verona Pharma
VRNA
$5.49M 0.52%
51,450
+23,000
OACCU
44
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
$5.48M 0.51%
516,482
TEVA icon
45
Teva Pharmaceuticals
TEVA
$30.7B
$5.41M 0.51%
267,816
-78,062
RYTM icon
46
Rhythm Pharmaceuticals
RYTM
$7.01B
$5.01M 0.47%
49,571
+4,181
ATAI icon
47
Atai Beckley NV
ATAI
$1.39B
$4.83M 0.45%
+913,242
UTHR icon
48
United Therapeutics
UTHR
$20.7B
$4.7M 0.44%
+11,200
VKTX icon
49
Viking Therapeutics
VKTX
$3.91B
$4.62M 0.43%
175,919
+108,106
REPL icon
50
Replimune Group
REPL
$762M
$4.1M 0.39%
978,894
+968,494
1
2
3 4 5